Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

Abbott Laboratories (ABT)

-NYSE
45.29 Down 0.73(1.59%) Aug 31, 4:01PM EDT
Add to Portfolio
Prev Close:46.02
Open:45.91
Bid:44.02 x 200
Ask:44.97 x 200
1y Target Est:55.23
Beta:1.21389
Earnings Date:Oct 20 - Oct 26 (Est.)
Day's Range:45.12 - 46.63
52wk Range:39.28 - 51.74
Volume:7,470,246
Avg Vol (3m):5,763,810
Market Cap:67.50B
P/E (ttm):15.22
EPS (ttm):2.98
Div & Yield:0.96 (2.06%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTDown 1.59%67.50B

Key Statistics

Forward P/E (1 yr):18.71
P/S (ttm):3.35
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :2.17
Quarterly EPS Est (Sep-15) :0.54
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback